脾切除治疗35例血液病的临床分析

目的探讨脾切除对血液病的治疗效果、适应证以及术后并发症。方法回顾分析2000年1至2010年1月云南省第一人民医院普外科治疗35例血液病患者的临床资料，探讨脾切除对血液病的治疗效果、术后并发症及预防措施。结果脾切除对原发性血小板减少性紫癜、遗传性球形红细胞增多症、自身性免疫性溶血性贫血治疗效果确切，有效率分别为87．5％、100％和83．3％。结论脾切除对内科治疗无效的良性血液病行之有效。

Splenectomy for hematological disease: an analysis of 35 cases

Objective To investigate the therapeutic efficacy, indications and postoperative complications of splenectomy in patients with hematological diseases. Methods The clinical data of 35 patients suffering from hematological diseases admitted between January 2000 and January 2010 at the general surgery department of the first people's hospital of yunnan province were analyzed retrospectively. The therapeutic efficacy, the postoperative complications and some preventive measures were discussed. Results Splenectomy could exert significant therapeutic effects on the diseases of idiopathic thrombocytopenic purpura(ITP), hereditary spherocytosis ( HS), autoimmune and hemolytic anemia ( AHA ). The effective rates were 87.5%, 100% and 83.3% respectively. Conclusion Splenectomy is effective on the benign hematological diseases whenever non-surgical management is invalid.